Compound information
- Natural Products
- ZC1343792
- Molecular Formula
- C14H18ClNO4S
- Molecular Weight
- 331.064506736 g/mol
- Structure
-
- IUPAC Name
- benzyl 4-(chlorosulfonylmethyl)piperidine-1-carboxylate
- InChI
- InChI=1S/C14H18ClNO4S/c15-21(18,19)11-13-6-8-16(9-7-13)14(17)20-10-12-4-2-1-3-5-12/h1-5,13H,6-11H2
- InChI Key
- JOQRDARBUIIJCV-UHFFFAOYSA-N
- SMILES
- O=C(OCc1ccccc1)N1CCC(CS(=O)(=O)Cl)CC1
- Source
- ZINC000100190572
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 63.68 Å2 | LogP | 2.255 |
LogS | -3.082 | LogD | 1.928 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.109 | Pgp substrate | 0.006 |
HIA | 0.971 | F20 % | 0.874 |
F30 % | 0.43 | Caco-2 | -4.493 |
MDCK | -4.763 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.233 | PPB | 73.486 |
VD | 0.263 | Fu | 0.619 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.487 | CYP1A2 substrate | 0.464 |
CYP2A6 substrate | 0.426 | CYP2B6 substrate | 0.643 |
CYP2C19 inhibitor | 0.429 | CYP2C19 substrate | 0.757 |
CYP2C8 substrate | 0.616 | CYP2C9 inhibitor | 0.412 |
CYP2C9 substrate | 0.703 | CYP2D6 inhibitor | 0.022 |
CYP2D6 substrate | 0.597 | CYP2E1 substrate | 0.15 |
CYP3A4 inhibitor | 0.059 | CYP3A4 substrate | 0.95 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.561 | CL | 3.147 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.533 | Hepatotoxicity | 0.991 |
Mutagenicity | 1.0 | Rat Oral Acute Toxicity | 0.027 |
FDAMDD | 0.78 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.468 | Eye Corrosion | 0.013 |
Eye Irritation | 0.256 | Respiratory Toxicity | 0.459 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.302 | IGC50 | 3.279 |
LC50FM | 3.618 | LC50DM | 5.318 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.34 | NR-AR-LBD | 0.184 |
NR-AhR | 0.007 | NR-Aromatase | 0.044 |
NR-ER | 0.235 | NR-ER-LBD | 0.42 |
NR-PPAR-gamma | 0.186 | SR-ARE | 0.531 |
SR-ATAD5 | 0.257 | SR-HSE | 0.086 |
SR-MMP | 0.025 | SR-p53 | 0.014 |
Similar covalent drugs
No similar covalent drugs found for this compound.